Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a family program stop diabetes before it starts?

NCT ID NCT07808723

Prevention Sponsor: Morehouse School of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 18, 2026 · Updated 2 times

Summary

Researchers are testing a weekly family-based lifestyle program called Family DPP+ to see if it helps parents with prediabetes lose weight and adopt healthier habits. The trial enrolls African American and Hispanic parents and their children in Georgia. Parents attend sessions for 12 weeks, and researchers track weight and lifestyle changes at the end of the program and three months later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a weekly family-based lifestyle program called Family Diabetes Prevention (Family DPP+)
What this could lead to
If it works, this could give families a practical, home-based way to lower their risk of type 2 diabetes together.
What could go wrong
The trial is small and early, so results may not hold up in larger groups. Lifestyle programs often struggle with long-term weight loss and keeping participants engaged.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Parent/guardian must identify as African American or Hispanic * Parent/guardian must be 18+ years residing in the same household as the child (i.e., biological or have legal guardianship for child) * Parent/guardian must have prediabetes (HbA1c level 5.7-6.4%) or be at risk of developing Type 2 diabetes using CDC's Pre-Diabetes Risk Test * Participant is willing to commit to participation in a 12-week, in-person, intervention study * No plans to move over the next 9-months * Parent/guardian should be ambulatory and able to participate in physical activity * Children must be between the ages of 12-17 years old * Child should be ambulatory and able to participate in physical activity Exclusion Criteria: * Severe psychological disorders that may prevent/interfere with study -participation * Physical impairments that may prevent participation in moderate intensity physical activity * Previous diagnosis of diabetes * History of congestive heart failure * Renal failure * Recent (\<12 months) cardiovascular events such as myocardial infarction (heart attack) or stroke * Taking medications that may affect endpoint analyses * Have co-morbid contraindications to physical activity or dietary changes * Currently pregnant or planning to become pregnant in the next year * Family lives outside of Georgia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prediabetes are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prediabetes syndrome Weight Loss type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prediabetes Weight reduction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Morehouse School of Medicine

    RECRUITING

    Atlanta, Georgia, 30310, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.